WeVote
Log In

Bill

Bill

SJR 16

Proposing an amendment to the Oregon Constitution relating to the death penalty.

2025 Regular Session Introduced by Lew Frederick

Designates October as Eczema Awareness Month in New Jersey, urges a yearly gubernatorial proclamation to boost awareness and education, with no new funding.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · SJR 16

Summary — SJR 16 (Joint Resolution)

Designates October of each year as “Eczema Awareness Month” in New Jersey

Purpose / Intent

SJR 16 is a commemorative joint resolution intended to increase public awareness of eczema — a group of chronic skin conditions — and to promote understanding, support, and educational activities for people living with the condition in New Jersey.

Key provisions

  • Designates October of each year as “Eczema Awareness Month” in New Jersey.
  • Requests that the Governor annually issue a proclamation designating October as Eczema Awareness Month and call upon public officials and citizens to observe the month with appropriate activities and programs.
  • Directs that copies of the resolution, as filed with the Secretary of State, be transmitted to the National Eczema Association.
  • Provides that the resolution takes effect immediately.

Background / Context included in the resolution

  • Defines eczema (red, itchy, inflamed skin) and lists common symptoms and triggers (stress, sweat, soaps/detergents, allergens).
  • Notes that eczema often appears in childhood but can present at any age; it can be episodic with flare-ups.
  • Cites prevalence estimates: roughly 32+ million Americans affected, ~10% national prevalence and over 13% prevalence in New Jersey.
  • Mentions common treatments (bathing/moisturizing routines, OTC and prescription topical meds, phototherapy, immunosuppressants, biologics, and alternative treatments).
  • References the American Academy of Dermatology estimate that treatment and related costs may be as high as $3.8 billion per year and highlights the social and emotional burden (stigma, social avoidance, depression, sleep loss).

Who is affected / likely impact

  • Primarily symbolic: individuals with eczema, patient and advocacy groups (e.g., National Eczema Association), health care providers, schools, community organizations, and the general public.
  • No regulatory or funding changes: the resolution does not create new rights, obligations, programs, or appropriations. Its primary effect is awareness-raising and encouraging voluntary activity and outreach.
  • Potential indirect benefits: increased public awareness could lead to greater education, reduced stigma, and support for research and access to care, but none are mandated by the resolution.

Legislative status and sponsors

  • Classification: Joint resolution (ceremonial/commemorative).
  • Introduced: November 12, 2024.
  • Status (as provided): Introduced in the Senate and referred to the Senate Health, Human Services and Senior Citizens Committee.
  • Primary sponsors: Senator Crowell and Representative McNair (and others listed in the document).
  • Effectiveness: takes effect immediately upon adoption.

Note: This is a commemorative resolution rather than a statute — it encourages proclamation and observance but does not create legal entitlements or fund programs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.